首页> 外文期刊>World Journal of Gastroenterology >Effect of somatostatin analogue octreotide injected into the third cerebral ventricle on pentagastrin-induced gastric acid secretion in rats.
【24h】

Effect of somatostatin analogue octreotide injected into the third cerebral ventricle on pentagastrin-induced gastric acid secretion in rats.

机译:向第三脑室注射生长抑素类似物奥曲肽对五肽胃泌素诱导的大鼠胃酸分泌的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the effect of long-lasting somatostatin analogue octreotide (Oct) injected into the third cerebral ventricle (TCV) on gastric acid secretion in rats. METHODS: TCVs were cannulated in male Wistar rats anesthetized with sodium pentobarbital. One week later acute gastric lumen perfusion was carried out and gastric acid was continuously washed with 37 degree Celsius saline by a perfusion pump. Gastric perfusion samples were collected every 10 min and titrated by 0.01 moL/L NaOH to neutral. On the basis of subcutaneous (sc) injection of pentagastrin (G-5, 160 microg/kg), Oct (0.025 microg, 0.05 microg, 0.1 microg, n=12 in each group) or vehicle (pyrogen-free physiological saline, n=10) was injected into the TCV. Before and after the TCV injection, 1 h total acid output (TAO) was determined and experimental data were expressed in change rate (%) of TAO. RESULTS: Oct (0.025, 0.05 and 0.1 microg) injected into the TCV resulted in change rate of 1.56% (P>0.05), 20.21% (P<0.01) and 37.82% of TAO (P<0.001), respectively. Moreover, comparison in change rate of TAO among these 3 doses showed P<0.05 between 0.025 microg and 0.05 microg, P<0.01 between 0.025 microg and 0.1 microg, and P<0.05 between 0.05 microg and 0.1 microg. However, sc injection of 0.05 microg Oct had no effect on G-5 stimulated gastric acid secretion. CONCLUSION: Octreotide injected into the third cerebral ventricle inhibits gastrin-induced gastric acid secretion in a dose-dependent manner.
机译:目的:研究向第三脑室(TCV)中注射长抑素类似物奥曲肽(Oct)对大鼠胃酸分泌的影响。方法:在戊巴比妥钠麻醉的雄性Wistar大鼠中插管TCV。一周后进行急性胃腔灌注,并通过灌注泵用37摄氏度的盐水连续洗涤胃酸。每10分钟收集一次胃灌流样本,并用0.01 moL / L NaOH滴定至中性。皮下注射五肽胃泌素(G-5,160微克/千克),十月(0.025微克,0.05微克,0.1微克,每组n = 12)或赋形剂(无热原生理盐水,n = 10)注入TCV。 TCV注射前后,测定1小时的总酸输出量(TAO),并以TAO的变化率(%)表示实验数据。结果:TCV注射Oct(0.025、0.05和0.1 microg)分别导致TAO的变化率为1.56%(P> 0.05),20.21%(P <0.01)和37.82%(P <0.001)。此外,比较这三种剂量中TAO的变化率,显示0.025μg至0.05μg之间P <0.05,0.025μg至0.1μg之间P <0.01,以及0.05μg至0.1μg之间P <0.05。然而,皮下注射0.05微克Oct对G-5刺激的胃酸分泌没有影响。结论:注射入第三脑室的奥曲肽以剂量依赖性方式抑制胃泌素诱导的胃酸分泌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号